Luciane Beatriz Kern

Luciane Beatriz Kern

Auto-generated profile, based on publicly available information

Luciane Beatriz Kern

Responsabilidade Social, Hospital Moinhos de Vento, Porto Alegre, RS, Brasil

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2023 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
TSTatiana Schnorr Silva
Tatiana Schnorr Silva
JHJaqueline Driemeyer Correia Horvath
Jaqueline Driemeyer Correia Horvath
MPMariana Pinto Pereira
Mariana Pinto Pereira
CDCaroline Nespolo de David
Caroline Nespolo de David
DVDora Fraga Vargas
Dora Fraga Vargas
CAClaudia Caceres Astigarraga
Claudia Caceres Astigarraga
Introduction: The time elapsed from diagnosis to hematopoietic stem cell transplantation (HSCT) is influenced by numerous factors. In Brazil, patients using the public health system are also dependent on the availability of HSCT-specific beds in the hematology ward. Objective and Methods We conducted a cohort study of listed patients who underwent allogeneic HSCT at a Brazilian public hospital to investigate the impact of the waitlist time on post-HSCT survival. Results: The median time from diagnosis to HSCT was 19 months (IQR, 10 - 43), of which 6 months (IQR, 3 - 9) were spent on the waitlist. The time on the waitlist for HSCT appeared to influence mainly the survival of adult patients (≥ 18 years), with an increasing risk according to this time (RR, 3.53 and 95%CI, 1.81 - 6.88 for > 3 and ≤ 6 months; RR 5.86 and 95%CI, 3.26 - 10.53 for > 6 and ≤ 12 months, and; RR 4.24 and 95%CI, 2.32 - 7.75 for > 12 months). Conclusion: Patients who remained on the waitlist for less than 3 months had the highest survival (median survival, 856 days; IQR, 131 - 1607). The risk of reduced survival was about 6-fold higher (95%CI, 2.8 - 11.5) in patients with malignancies.

16 January 2022 in Diagnostic Microbiology and Infectious Disease
Verified
Journal Article
Closed access
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
FVFernanda Hammes Varela
Fernanda Hammes Varela
MMMariana Rost MEIRELES
Mariana Rost MEIRELES
LKLuciane Beatriz Kern
Luciane Beatriz Kern
TAThaís Raupp Azevedo
Thaís Raupp Azevedo
MPMárcia Polese-Bonatto
Márcia Polese-Bonatto

1 March 2022 in Jornal de Pediatria
Verified
Journal Article
Open access
MSMarcelo Comerlato Scotta
Marcelo Comerlato Scotta
CDCaroline Nespolo de David
Caroline Nespolo de David
FVFernanda Hammes Varela
Fernanda Hammes Varela
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
MPMárcia Polese-Bonatto
Márcia Polese-Bonatto
RSRenato T. Stein
Renato T. Stein
To evaluate the accuracy of an antibody point-of-care lateral flow immunoassay (LFI - Wondfo Biotech Co., Guangzhou, China) in a pediatric population. Children and adolescents (2 months to 18 years) with signs and symptoms suggestive of acute SARS-CoV-2 infection were prospectively investigated with nasopharyngeal RT-PCR and LFI at the emergency room. RT-PCR was performed at baseline, and LFI at the same time or scheduled for those with less than 7 days of the clinical picture. Overall accuracy, sensitivity and specificity were assessed, as well as according to the onset of symptoms (7-13 or ≥14 days) at the time of LFI test. In 175 children included, RT-PCR and LFI were positive in 51 (29.14%) and 36 (20.57%), respectively. The overall sensitivity, specificity, positive and negative predictive value was of 70.6% (95%CI 56.2-82.5), 96.8% (95%CI 91.9-99.1), 90.0% (95%CI 77.2-96.0), and 88.9% (95%CI 83.9-92.5), respectively. At 7-13 and ≥14 days after the onset of symptoms, sensitivity was 60.0% (95%CI 26.2-87.8) and 73.2% (95%CI 57.1-85.8) and specificity was 97.9% (95%CI 88.7-99.9) and 96.1% (95%CI 89.0-99.2), respectively. Despite its high specificity, in the present study, the sensitivity of LFI in children was lower (around 70%) than most reports in adults. In acute care settings, although a positive result is informative, a negative LFI test cannot rule out COVID-19 in children.

20 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
MPMárcia Polese-Bonatto
Márcia Polese-Bonatto
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
FVFernanda Hammes Varela
Fernanda Hammes Varela
GGGabriela Luchiari Tumioto Gianinni
Gabriela Luchiari Tumioto Gianinni
TAThaís Raupp Azevedo
Thaís Raupp Azevedo
RSRenato T. Stein
Renato T. Stein
Background The viral dynamics and the role of children in the spread of SARS-CoV-2 are not completely understood. Our aim was to evaluate how RT-PCR Ct values among children with confirmed SARS-CoV-2 compared with that of adult subjects. Methods Patients (aged from 2 months to ≤18 years, and adults) with signs and symptoms of acute SARS-CoV-2 infection for less than 7 days, were prospectively enrolled in the study from May to November 2020. All participants performed RT-PCR assay for SARS-CoV-2 detection; Ct values of ORF1ab, N, and S gene-targets, and the average of all the three probes were used as surrogates of viral load. Results Of the total of 376 participants with confirmed SARS-CoV-2 infection there were 21 infants, 62 children and 293 adults. The RT-PCR Ct values of children under 18 were not significantly different from that of adults, as observed by the analyzed probes (namely ORF1ab, N, and S), and by the mean of all 3 gene-targets. However, infants had significantly lower Ct values compared to children and adults (P = 0.044). Discussion Ct values for children were not significantly different than that of adults with positive SARS-CoV-2. Interestingly, infants had even lower Ct values when compared to older children and adults. Although viral load is not the only determinant of transmission, infants may play a significant role in the spread of SARS-CoV-2 in the community, especially if or when this population returns to regular daycare activities.

1 January 2022 in Cadernos de Saude Publica
Verified
Journal Article
Open access
CDCaroline Nespolo de David
Caroline Nespolo de David
FVFernanda Hammes Varela
Fernanda Hammes Varela
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
MPMárcia Polese-Bonatto
Márcia Polese-Bonatto
IFIngrid Rodrigues Fernandes
Ingrid Rodrigues Fernandes
MSMarcelo Comerlato Scotta
Marcelo Comerlato Scotta
Point-of-care serological tests for SARS-CoV-2 have been used for COVID-19 diagnosis. However, their accuracy over time regarding the onset of symptoms is not fully understood. We aimed to assess the accuracy of a point-of-care lateral flow immunoassay (LFI). Subjects, aged over 18 years, presenting clinical symptoms suggestive of acute SARS-CoV-2 infection were tested once by both nasopharyngeal and oropharyngeal RT-PCR and LFI. The accuracy of LFI was assessed in periodic intervals of three days in relation to the onset of symptoms. The optimal cut-off point was defined as the number of days required to achieve the best sensitivity and specificity. This cut-off point was also used to compare LFI accuracy according to participants’ status: outpatient or hospitalized. In total, 959 patients were included, 379 (39.52%) tested positive for SARS-CoV-2 with RT-PCR, and 272 (28.36%) tested positive with LFI. LFI best performance was achieved after 10 days of the onset of symptoms, with sensitivity and specificity of 84.9% (95%CI: 79.8-89.1) and 94.4% (95%CI: 91.0-96.8), respectively. Although the specificity was similar (94.6% vs. 88.9%, p = 0.051), the sensitivity was higher in hospitalized patients than in outpatients (91.7% vs. 82.1%, p = 0.032) after 10 days of the onset of symptoms. Best sensitivity of point-of-care LFI was found 10 days after the onset of symptoms which may limit its use in acute care. Specificity remained high regardless of the number of days since the onset of symptoms.

5 August 2021 in medRxiv
Verified
Preprint
Open access
PDF file
ISIvaine Tais Sauthier Sartor
Ivaine Tais Sauthier Sartor
CDCaroline Nespolo de David
Caroline Nespolo de David
GTGabriela Heiden Telo
Gabriela Heiden Telo
GZGabriela Oliveira Zavaglia
Gabriela Oliveira Zavaglia
IFIngrid Rodrigues Fernandes
Ingrid Rodrigues Fernandes
RSRenato T. Stein
Renato T. Stein
Background/Objectives: The aim of this study was to evaluate the association between obesity and hospitalization in mild COVID-19 adult outpatients in Brazil. Subjects/Methods: Adults with signs and symptoms suggestive of acute SARS-CoV-2 infection who sought two hospitals (one public and one private) emergency department (ED) were prospectively enrolled. Patients with confirmed COVID-19 at inclusion were followed by phone calls at day (D) D7, D14 and D28. Multivariable logistic regression models were employed to explore the association between obesity and other potential predictors for hospitalization. Results: A total of 1,050 participants were screened, 310 were diagnosed with COVID-19 by RT-PCR. Median age was 37.4 (IQR 29.8-45.0) years, and 186 (60.0%) were female. Duration of symptoms was 3.0 (IQR 2.0-5.0) days, and 10.0 (IQR 8.0-12.0) was the median number of symptoms at inclusion. A total of 98 (31.6%) were obese, and 243 (78.4%) had no previous medical conditions. Twenty three participants (23/310, 7.4%) required hospitalization during the period. After adjusting, obesity (BMI≥30.0 kg/m 2 ) (OR=2.69, 95%CI 1.63-4.83, P<0.001) and older age (OR=1.05, 95%CI 1.01-1.09, P<0.001), were significantly associated with higher risks of hospitalization. Conclusions: Obesity, followed by aging, was the main factor associated with hospital admission for COVID-19 in a young population in a low-middle income country. Our findings highlighted the need for actions to promote additional protection for obese population, such as vaccination, and to encourage lifestyle changes.